Adjuvant therapy on Fagopyrum ulcerative colitis.docVIP

 PAGE \* MERGEFORMAT 6 Adjuvant therapy on Fagopyrum ulcerative colitis Study: Jiong Wu Jian, Wang Songpa, Wang Peiwen [Keywords:] Ulcerative colitis; Fagopyrum; treatment Ulcerative colitis is an inflammation of the rectum and colon diseases [1], lesions largely confined to the lower intestinal mucosa, the cause has not been fully clarified, the current infection is generally considered secondary to a predisposing factor or disease-based [2], the author adopts Nantong Essence Pharmaceutical Co., Ltd. joint film production of Fagopyrum Western treatment of ulcerative colitis patients, a significant effect. 1 Materials and Methods 1.1 General information on 64 patients in this group for the years 2007-2009 in our hospital gastroenterology clinic and hospital patients, diagnostic criteria consistent with the Chinese Society of Gastroenterology Inflammatory Bowel Disease Collaborative Group in 2007 on the diagnosis and treatment of inflammatory bowel disease Consensus norms. All patients had varying degrees of persistent or recurrent abdominal pain, mucus, pus and blood will, and by electronic colonoscopy and pathological diagnosis of active UC, were randomly divided into two groups: treatment group 32 patients, 17 males and 15 females , aged 18 to 60 years (mean 41.2 years), duration of 3 months to 15 years, 10 patients with mild, moderate 12 cases and severe in 10 cases. pathogenesis of parts: 13 cases of straight sigmoid, descending colon in 11 cases, the entire colon 8 cases. relapsing in 20 cases, 6 cases of chronic persistent, early onset in 6 patients. the control group of 32 patients, 16 males and 16 females, aged 19 to 58 years (mean 39.8 years), duration of 4 months to 16 years , of which 14 patients with mild, moderate in 9 cases, severe in 9 patients. pathogenesis parts: straight sigmoid colon in 12 cases, 13 cases of descending colon, the entire colon in 7 cases. relapsing in 18 cases, 7 cases of chronic persistent, early onset in 7 cas